6 Followers on Owler

Bio-Path

Read more
Peter Nielsen's photo - President & CEO of Bio-Path

President & CEO

Peter Nielsen

CEO Approval Rating

88/100

Founded:

2007

Status:

PublicIndependent CompanyNASDAQBPTH

Bio-Path Quarterly and Annual Revenue

Coming soon for Bio-Path!

Annual Revenue

$ < 1M

Bio-Path's revenue is the ranked 21th among it's top 10 competitors. The top 10 competitors average 3.8B.

Bio-Path News

Bio-Path Press Releases

Social Media

Bio-Path Headquarters

4710 Bellaire Blvd Suite 210

Bellaire, Texas77401

832-742-1357

Driving Directions »

Bio-Path Summary

ABOUT

Overview

Bio-Path develops and commercializes DNA therapeutics for the treatment of acute myeloid leukemia and solid tumors. Bio-Path was founded in 2007. Bio-Path's headquarters is located in Bellaire, Texas, USA 77401. It has raised 7.9M in 5 rounds. The lat...

CEO

Bio-Path's President & CEO, Peter Nielsen, currently has an approval rating of 88%. Bio-Path's primary competitors are Inovio, Infinity Pharmaceuticals & Icagen.

Acquisitions

There have been no acquisitions found related to Bio-Path

Investments

Recent investment data cannot be found related to Bio-Path

Frequently Asked Questions about Bio-Path

  1. When was Bio-Path founded?

    Bio-Path was founded in 2007
  2. Who is Bio-Path's CEO?

    Bio-Path's CEO is Peter Nielsen
  3. How much revenue does Bio-Path generate?

    Bio-Path generates $ < 1M in revenue
  4. How much funding does Bio-Path have?

    Bio-Path has historically raised $7.9M in funding
  1. Where is Bio-Path's headquarters?

    Bio-Path's headquarters is in Bellaire Texas, USA
  2. How many employees does Bio-Path have?

    Bio-Path has 8 employees
  3. What sector does Bio-Path operate in?

    Bio-Path is in Medical Research & Laboratories, Pharmaceuticals
  4. Who are Bio-Path's competitors?

    Bio-Path's top competitors are Inovio, Infinity Pharmaceuticals, Icagen

Trending Companies